Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study.
Grasa E, Seppälä J, Alonso-Solis A, Haapea M, Isohanni M, Miettunen J, Caro Mendivelso J, Almazan C, Rubinstein K, Caspi A, Unoka Z, Farkas K, Usall J, Ochoa S, van der Graaf S, Jewell C, Triantafillou A, Stevens M, Reixach E, Berdun J; m-RESIST group; Corripio I. Grasa E, et al. Among authors: triantafillou a. JMIR Form Res. 2023 Jun 30;7:e46179. doi: 10.2196/46179. JMIR Form Res. 2023. PMID: 37389933 Free PMC article.
Automated office blood pressure measurements in primary care are misleading in more than one third of treated hypertensives: The VALENTINE-Greece Home Blood Pressure Monitoring study.
Kollias A, Papadatos SS, Dominiczak AF, Parati G, Stergiou GS; Valentine-Greece Home Blood Pressure Monitoring Study Group. Kollias A, et al. Hellenic J Cardiol. 2020 May-Jun;61(3):174-177. doi: 10.1016/j.hjc.2019.01.005. Epub 2019 Jan 9. Hellenic J Cardiol. 2020. PMID: 30639355 Free article.
Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.
Alonso-Solís A, Rubinstein K, Corripio I, Jaaskelainen E, Seppälä A, Vella VA, Caro-Mendivelso J, Caspi A, Isohanni M, Unoka Z, Van der Graff S, Farkas K, Huerta-Ramos E, Marcó-García S, Stevens M, Coenen T, Hospedales M, Berdún J; m-Resist group; Grasa EM. Alonso-Solís A, et al. BMJ Open. 2018 Jul 16;8(7):e021346. doi: 10.1136/bmjopen-2017-021346. BMJ Open. 2018. PMID: 30012788 Free PMC article.
Validation of the Multiple Sclerosis International Quality of Life questionnaire.
Simeoni M, Auquier P, Fernandez O, Flachenecker P, Stecchi S, Constantinescu C, Idiman E, Boyko A, Beiske A, Vollmer T, Triantafyllou N, O'Connor P, Barak Y, Biermann L, Cristiano E, Atweh S, Patrick D, Robitail S, Ammoury N, Beresniak A, Pelletier J; MusiQol study group. Simeoni M, et al. Mult Scler. 2008 Mar;14(2):219-30. doi: 10.1177/1352458507080733. Epub 2007 Oct 17. Mult Scler. 2008. PMID: 17942521
Inhaled nitric oxide improves lung allograft function after prolonged storage.
Okabayashi K, Triantafillou AN, Yamashita M, Aoe M, DeMeester SR, Cooper JD, Patterson GA. Okabayashi K, et al. Among authors: triantafillou an. J Thorac Cardiovasc Surg. 1996 Aug;112(2):293-9. doi: 10.1016/s0022-5223(96)70252-0. J Thorac Cardiovasc Surg. 1996. PMID: 8751493 Free article.
29 results